
Sign up to save your podcasts
Or
Dr Dave Maplesden, Dr Jo Scott-Jones discuss Naloxone, OCP and risk of PE, Ovarian Cancer Diagnosis amongst other topical clinical updates with contributions from audience members Dr Marlene Bezuidenhout and Dr Natalie Clarke.
Dr Dave Maplesden, Dr Jo Scott-Jones discuss Naloxone, OCP and risk of PE, Ovarian Cancer Diagnosis amongst other topical clinical updates with contributions from audience members Dr Marlene Bezuidenhout and Dr Natalie Clarke.
21 Listeners
41 Listeners
590 Listeners
9 Listeners
26 Listeners
20 Listeners
17 Listeners
47 Listeners
53 Listeners
17 Listeners
243 Listeners
17 Listeners
78 Listeners
751 Listeners
13 Listeners